Verily (formerly Google Life Sciences ) is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until 10 August 2015 when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.  This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.  
As of July 2014, members of the research team include Andrew Conrad, founder of LabCorp's National Genetics Institute; Vik Bajaj, an expert in nuclear magnetic resonance; Marija Pavlovic, who studies the effect of radiation on DNA; Alberto Vitari, a cancer biologist; Brian Otis, who worked on Google Venture's glucose-sensing contact lens; and Mark DePristo, who worked on the GATK at the Broad Institute.  Dr. Thomas R. Insel announced on Sept. 15, 2015, that he was resigning as the director of the National Institute of Mental Health (NIMH) to join this division. 
On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.
- Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method. 
- A spoon for people with tremors.
- The Baseline Study, a project to collect genetic, molecular, and wearable device information from enough people to create a picture of what a healthy human should be. 
- A health-tracking wristband.
- A disease-detecting nanoparticle platform working with the wristband, a project called Tricorder. 
- Advancements in surgical robotics, in partnership with Johnson & Johnson. 
- Development and commercialization of bioelectronic medicines, in partnership with GlaxoSmithKline 
- Development of miniaturized continuous glucose monitors (CGM) in partnership with Dexcom